Perceptive Devices, a company specializing in hands-free and voice-free electronic devices, is partnering with eye tracking device maker Tobii Dynavox to develop…
Articles by Charles Moore
Radicava (edaravone), the first new medication for amyotrophic lateral sclerosis (ALS) in 22 years, is now available in the United States.
Brazilian doctors have begun prescribing HempMeds Brasil‘s hemp cannabis oil to ALS and psoriasis patients, the company’s U.S. parent reports.
Pfizer and AbbVie are pumping $10 million into Aquinnah Pharmaceuticals‘ effort to develop a revolutionary approach to treating neurodegenerative diseases…
May is ALS Awareness Month and the ALS community is seeking the help of individuals willing to participate, advocate and…
Regenerative medicine investigators at the Cedars-Sinai Medical Center have received U.S. Food and Drug Administration (FDA) approval to test a…
“Die Trying”, this Friday’s episode of HBO’s edgy half-hour newsmagazine series VICE, is about ALS and hosted by the show’s…
Over the summer and fall of 2016, 93 WALKs for ALS events will be held across Canada, organized by…
New Pensacola, Florida-based aerospace company Gulf Coast Aerospace Partners is the presenting sponsor of the first annual Gulf…
This year’s ALS Association-sponsored Drug Company Working Group meeting — to review recent trial results and discuss new developments…